Taiwo Oladapo

Array ( [id] => 7367446 [patent_doc_number] => 20040092469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Androgen-regulated PMEPA1 gene and polypeptides' [patent_app_type] => new [patent_app_number] => 10/434479 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36964 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092469.pdf [firstpage_image] =>[orig_patent_app_number] => 10434479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448720 [patent_doc_number] => 20040009920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Methods and compositions for inhibiting tumor growth and angiogenesis' [patent_app_type] => new [patent_app_number] => 10/431642 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10665 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009920.pdf [firstpage_image] =>[orig_patent_app_number] => 10431642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966494 [patent_doc_number] => 20050233391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Soluble mic polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions' [patent_app_type] => utility [patent_app_number] => 10/512181 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31339 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233391.pdf [firstpage_image] =>[orig_patent_app_number] => 10512181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7219983 [patent_doc_number] => 20040072196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Novel serpentine transmembrane antigens expressed in human cancers and uses therefor' [patent_app_type] => new [patent_app_number] => 10/408009 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 21728 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072196.pdf [firstpage_image] =>[orig_patent_app_number] => 10408009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710472 [patent_doc_number] => 20060051817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Method for diagnosing neoplasms' [patent_app_type] => utility [patent_app_number] => 10/512935 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6945 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051817.pdf [firstpage_image] =>[orig_patent_app_number] => 10512935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612656 [patent_doc_number] => 07989176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Treating cancer' [patent_app_type] => utility [patent_app_number] => 10/508873 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 35 [patent_no_of_words] => 20395 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989176.pdf [firstpage_image] =>[orig_patent_app_number] => 10508873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793136 [patent_doc_number] => 20060013817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Genetic products differentially expressed in tumors and use thereof' [patent_app_type] => utility [patent_app_number] => 10/506443 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20509 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013817.pdf [firstpage_image] =>[orig_patent_app_number] => 10506443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110601 [patent_doc_number] => 20050208056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Neoplasm specific antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/506763 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15564 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208056.pdf [firstpage_image] =>[orig_patent_app_number] => 10506763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770376 [patent_doc_number] => 20030216316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Pharmaceutical compositions comprising erythropoietin for treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/378970 [patent_app_country] => US [patent_app_date] => 2003-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8682 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216316.pdf [firstpage_image] =>[orig_patent_app_number] => 10378970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675720 [patent_doc_number] => 20040126398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/181663 [patent_app_country] => US [patent_app_date] => 2003-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8552 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126398.pdf [firstpage_image] =>[orig_patent_app_number] => 10181663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678451 [patent_doc_number] => 20030228592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Human facilitative glucose transport protein GLUT8' [patent_app_type] => new [patent_app_number] => 10/367980 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10556 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228592.pdf [firstpage_image] =>[orig_patent_app_number] => 10367980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6824911 [patent_doc_number] => 20030235533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Prostate specific genes and the use thereof in design or therapeutics' [patent_app_type] => new [patent_app_number] => 10/367978 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 31103 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235533.pdf [firstpage_image] =>[orig_patent_app_number] => 10367978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135951 [patent_doc_number] => 20050180971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Cancer therapy' [patent_app_type] => utility [patent_app_number] => 10/503794 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8533 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180971.pdf [firstpage_image] =>[orig_patent_app_number] => 10503794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 556404 [patent_doc_number] => 07470510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Methods for diagnosing cancer and determining a susceptibility for developing cancer' [patent_app_type] => utility [patent_app_number] => 10/364515 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11986 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470510.pdf [firstpage_image] =>[orig_patent_app_number] => 10364515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602586 [patent_doc_number] => 07432349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Tumor suppressor gene, p28ING5' [patent_app_type] => utility [patent_app_number] => 10/502431 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30071 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432349.pdf [firstpage_image] =>[orig_patent_app_number] => 10502431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323487 [patent_doc_number] => 20040137442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Amplified and overexpressed gene in colorectal cancers' [patent_app_type] => new [patent_app_number] => 10/346367 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13185 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137442.pdf [firstpage_image] =>[orig_patent_app_number] => 10346367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855689 [patent_doc_number] => 20030129190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'FX activity in cells in cancer, inflammatory responses and diseases and in autoimmunity' [patent_app_type] => new [patent_app_number] => 10/342323 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9154 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129190.pdf [firstpage_image] =>[orig_patent_app_number] => 10342323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 453411 [patent_doc_number] => 07247700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-24 [patent_title] => 'BID polypeptides and methods of inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 10/334006 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25463 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247700.pdf [firstpage_image] =>[orig_patent_app_number] => 10334006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288641 [patent_doc_number] => 20040109863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express Ly-9' [patent_app_type] => new [patent_app_number] => 10/328538 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21499 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20040109863.pdf [firstpage_image] =>[orig_patent_app_number] => 10328538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710495 [patent_doc_number] => 20030170244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Inhibition of Fas signaling' [patent_app_type] => new [patent_app_number] => 10/318772 [patent_app_country] => US [patent_app_date] => 2002-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9810 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170244.pdf [firstpage_image] =>[orig_patent_app_number] => 10318772 [rel_patent_id] =>[rel_patent_doc_number] =>)